August 9, 2017– Cempra, Inc. (Nasdaq: CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for acute care and ...
Aug 10, 2017 ... But one detail should not go unnoticed: Cempra and Melinta have together taken $1.1bn of investor money, and turned that into an asset ...
Aug 9, 2017 ... 09, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated ...
As of November 3, 2017, Cempra, Inc. was acquired by Melinta Therapeutics, Inc. , in a reverse merger transaction. Cempra, Inc., a clinical-stage pharmaceutical ...
Learn about working at Cempra Pharmaceuticals. ... See who you know at Cempra Pharmaceuticals, leverage your professional network, and ... Chimerix, Inc.
View the basic CEMP stock chart on Yahoo Finance. Change the date range, chart type and compare CEMPRA INC against other companies.
Nov 8, 2017 ... Willkie represented Melinta Therapeutics, Inc. and Vatera Healthcare Partners, Melinta's majority shareholder, in its merger with Cempra, Inc.
GEMP, Gemphire Therapeutics Inc. 1.69, N/A, Stocks, NGM. CCMP, Cabot ... Stocks, NCM. CEM, ClearBridge Energy MLP Fund Inc, 14.09, N/A, Stocks, NYQ.